Person

Kieran Gallahue

Director, Edwards Lifesciences

Current S&P 500 boards
1
Current roles
1
Open-market buys
$524K
Open-market sales
$3.8M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 23, 2024EWSale3,058$87.61$268K
Feb 8, 2022EWSale32,256$110.79$3.6M
Feb 3, 2017EWBuy3,000$90.10$270K
Nov 29, 2016EWBuy3,000$84.63$254K

SEC reporting-owner ID (CIK) 1308428 · all filings on EDGAR

Kieran Gallahue (EW) | USBoard